Almirall (Almirall) Short-Term Debt : $12.7 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Almirall Short-Term Debt?

Almirall's Short-Term Debt for the quarter that ended in Jun. 2023 was $12.7 Mil.

Almirall's quarterly Short-Term Debt declined from Dec. 2022 ($12.3 Mil) to Mar. 2023 ($0.0 Mil) but then increased from Mar. 2023 ($0.0 Mil) to Jun. 2023 ($12.7 Mil).

Almirall's annual Short-Term Debt declined from Dec. 2021 ($13.7 Mil) to Dec. 2022 ($12.3 Mil) and declined from Dec. 2022 ($12.3 Mil) to Dec. 2023 ($12.0 Mil).

Almirall Short-Term Debt Historical Data

The historical data trend for Almirall's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Short-Term Debt Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

4.06

300.80

13.75

12.30

12.00

Almirall Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															12.68	12.30	-	12.67	12.00

Almirall Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Almirall Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Almirall's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (Almirall) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.